Cimpress n.v, Company

(Prof) Dr Kannan Vishwanatth, noted academic researcher & Founder & Managing Director of Hong Kong based Rupus Global Limited, a globally acclaimed research-focused vertically integrated pharmaceutical Company, which contract manufactures active pharmaceutical ingredients (APIs), finished dosage forms (FDFs), and provides contract research and manufacturing services (CRAMS) with presence in over 75 countries was conferred the prestigious Honorary Professorship at University of California, Berkeley.(Prof) Dr Kannan Vishwanatth said, "I am "honoured and humbled" by the academic Board of The University of California - Berkeley's decision to confer on him the prestigious Professorship and expressed appreciation for the recognition of his work & look forward to a long-term fruitful association with University of California - Berkeley."(Prof) Dr Kannan Vishwanatth joins a prestigious academic group of individuals who have been similarly honored over the years at the University of California, Berkeley. (Prof) Dr Kannan Vishwanatth has been a Doctoral Fellow at the Institute of Professional Financial Managers, United Kingdom. (Prof) Dr Kannan Vishwanatth is best known for co-authoring & publishing notable milestones in the patents of transdermal formulations and Anti-Cancer API's.(Prof) Dr Kannan Vishwanatth has also been awarded the prestigious The Albert Schweitzer Medal in Science 2017, The Malcolm Adishesish Award for Development Studies 2020, The Professional Academic Award 2019, The American College Dubai UAE & GSIR Foundation, Outstanding Entreprenuer Award 2011, Asia Pacific Entrepreunership Award (APEA). (Prof) Dr Kannan Vishwanatth did Bachelor of Petroleum Engineering in the year 1992-1996 from Maharashtra Institute of Technology in Pune in India, followed by Asia-E-University and Indian Institute of Research and Management India Master's in Business Administration in the year 2008-2009. (Prof) Dr Kannan Vishwanatth further pursued higher studies from the University of Azteca European Programs and Indian Institute of Research and Management India Doctor of Philosophy in Business Management (2009-2012).Prof Dr Kannan Vishwanatth is a world leader in strategy and innovation, has presented many research papers in the international conferences, delivered keynote addresses in London, America, Paris, Germany etc.Rupus Global Limited is a market leader in the Antimalarial API segment and is the world's third-largest contract manufacturer of Quinine salts. Rupus Global Limited product portfolio consists of the second generation, Quinine-based antimalarial APIs, third-generation Artemisinin-based antimalarial APIs; Niche APIs, and FDFs complimented by APIs in HIV, Diabetes, Ace Inhibitor, and CNS.Rupus Global Limited has a distributor network of over 250 distributors in India and has entered into a marketing and distribution agreement with Rx Pharma (India) to distribute the company's products domestically. It also exports its products to more than 60 emerging countries in Africa, Central and South America, and Asia. The Company's API business has grown rapidly since its commencement in FY2018 and currently contributes over 60 per cent of total revenues while its formulations business contributes over 40 per cent of total revenues.Berkeley alumni, faculty and researchers include more Nobel laureates, Turing Award winners, Fields Medalists, Wolf Prize winners, and MacArthur "Genius Grant" recipients than those of any other public university in the nation; they have also won 30 Pulitzer Prizes and 19 Academy Awards. The university has produced seven heads of state or government; six chief justices, including Chief Justice of the United States Earl Warren; 22 cabinet-level officials; 11 governors; and 25 living billionaires. It is also a leading producer of Fulbright Scholars, MacArthur Fellows, and Marshall Scholars. Berkeley alumni, widely recognized for their entrepreneurship, have founded numerous notable companies, including Apple, Tesla, Intel, eBay, SoftBank, AIG, and Morgan Stanley etc.This story is provided by NewsVoir.will not be responsible in any way for the content of this article. (ANI/NewsVoir)( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Cimpress N.vFOLLOW

Cimpress n.v, Latest News

Inox Wind Limited, India's leading wind energy solutions provider, has on 2nd June, 2022 completed the allotment of equity shares at an issue price of Rs. 126/- (Rupees One Hundred and Twenty Six only) per equity share inclusive of a premium of Rs 11 ...

Advancing in its quest to build a sustainable hunger-free world, Sodexo India, on #WorldHungerDay culminated its annual month-long community-based event by providing food and ration items to communities where access to quality food continues to be a ...

TVS Motor Company's revenue from operations in Q4 grew by 4 per cent at Rs 5,530 Crores against Rs 5,322 Crores reported in the fourth quarter of 2020-21. ...

HDFC Life recently signed up for the UN-supported Principles for Responsible Investment (PRI), epitomising its objective of sustainable growth and long term value creation. ...

Gurgaon, April 28 On one hand the demand for residential and commercial properties is constantly moving up, and ... ...

Cimpress India, a shared strategic capability of Cimpress N.V, a group of ~15 e-commerce companies across the world, specializing in various domains of mass customization, has been certified as Great Place to Work 2022-23 by the Great Places to Work ...

India's largest carmaker Maruti Suzuki said on Monday it has increased the prices of its entire model range by an average of 1.3 per cent due to a sharp increase in input costs. ...

(Prof) Dr Kannan Vishwanatth, noted academic researcher & Founder & Managing Director of Hong Kong based Rupus Global Limited, a globally acclaimed research-focused vertically integrated pharmaceutical Company, which contract manufactures active phar ...